A targeted screening method for peripheral arterial disease: a pilot study
© Craike and Chuter 2015
Published: 22 September 2015
Podiatrists play a central role in conducting non-invasive vascular foot assessment in the general population. Routine clinical assessment of lower limb arterial flow in at risk patients is essential in early detection and monitoring of the disease. There are a variety of clinical examinations available to clinicians in order to determine adequacy of blood supply to the lower extremity. However, recent research suggests that certain conditions, such as advanced age, diabetes, renal failure and medial arterial calcification can affect the accuracy of some of these examinations. Currently, there are no specific guidelines dictating the most appropriate methods of assessing lower limb vascular status for Podiatrists. The purpose of this study was to develop and validate a targeted vascular screening method for podiatrists.
An extensive review of the literature was performed. Combined with recent research completed by the researchers, a targeted vascular screening method was developed. Two participant groups were recruited, a private practice group (N=31), and a public sector group (N=32). Two clinicians used the screening method to outline what assessment they would undertake. All non-invasive vascular testing along with colour duplex ultrasound was performed on all patients by a vascular ultrasonographer. Sensitivity and specificity of the methods chosen for detecting PAD were compared to the current American Heart Association (AHA) vascular screening guideline.
The targeted screening method demonstrated higher sensitivity (50%) than the AHA standard (33%) in the private participant group, and was equally as specific (88%). In participant group two, the targeted screening method was equally as sensitive to the AHA guideline (45.45%), but less specific (80.95% vs. 95.24%).
The targeted screening method could be used as a guideline for podiatrists to make their vascular assessment more accurate, resulting in a decrease in the number of false negatives in patients with suspected PAD.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.